The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAthelney Tst. Regulatory News (ATY)

Share Price Information for Athelney Tst. (ATY)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 177.50
Bid: 165.00
Ask: 190.00
Change: 0.00 (0.00%)
Spread: 25.00 (15.152%)
Open: 177.50
High: 177.50
Low: 177.50
Prev. Close: 177.50
ATY Live PriceLast checked at -
Athelney is an Investment Trust

To provide shareholders with prospects of long term capital growth by investing in companies with either a full listing on the London Stock Exchange or a trading facility on AIM or ISDX.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Net Asset Value(s)

6 Nov 2023 07:00

RNS Number : 4101S
Athelney Trust PLC
04 November 2023
 

Athelney Trust PLC

 

Legal Entity Identifier:

213800ON67TJC7F4DL05

The unaudited net asset value of Athelney Trust was 186.2p at 31 October 2023.

Fund Manager's comment for October 2023

In spite of the fact that the US economy expanded faster than expected in the third quarter, the equity risk premium increased materially in October. This was driven by fears that the Israel-Gaza war could involve more countries in the Middle East conflict and also disrupt the supply of oil as voluntary cuts by Saudi Arabia and Russia are still in place until the end of the year.

 

Furthermore, this week's confidence surveys confirmed a soft growth environment for Europe's major economies with the manufacturing PMI in contraction territory for the 16th straight month and the new orders component suggesting continued manufacturing weakness going forward. The news in the United Kingdom was only marginally better with the October services PMI easing further in September. This economic weakness and a substantial decline in Eurozone inflation prompted the European Central Bank to hold interest rates at 4%, bringing an end to its streak of 10 consecutive increases in borrowing costs. Whilst UK inflation cooled more than expected last month, June's 7.9% reading remains far higher than the Bank of England's 2% target and UK business activity contracted in October for the third consecutive month.

 

In a recently published survey by Stifel, it was shown that there are currently 35 investment trusts, investing primarily in shares, with a dividend yield of 4% or higher. Of these, the survey highlights those investment trusts, including Athelney, that have increased their annual dividend payout for at least 20 years in a row. Most funds comprise investments in the large-cap universe as they satisfy requirements for yield. However, there are three UK smaller companies' funds which have made the list this year with Athelney having the highest dividend yield of 4.9 per cent. The BlackRock Smaller Companies trust is on a yield of 3.1 per cent and the Henderson trust on 3.9 per cent with their current higher than normal yields resulting from poor share price performance over the past year.

 

During the month the NASDAQ was down by 2.78% with the S&P500 faring slightly better, declining by only 2.2%. In fact, markets globally were under pressure with the MSCI declining during the month by 2.97%. After a positive month in September, the FTSE100 was down, declining by 3.76% with the remainder of the market and in particular, the mid-cap companies substantially down. The FTSE 250 declined by 6.54%, with the AIM All-Share Index declining by 6.38%. The Small Cap Index was down by 6.13% and the Fledgling Index performed slightly better, down by 5.24%.

 

In periods when there is an increase in the equity risk premium, as occurred in October, the share prices of growth companies are affected the most as long dated earnings are discounted. This is the case for Athelney where in spite of the fact that investment income is the highest it has been since 2019, the value of the Athelney portfolio has declined by 6.77% during the month. After allowing for expenses, including a substantial increase in audit fees, the NAV reflected a decline of 7.78%.

 

There were no changes to the portfolio during the month. Our cash holding at month end was unchanged, comprising 3.2% of the portfolio.

 

Fact Sheet

An accompanying fact sheet which includes the information above as well as wider details on the portfolio can be found on the Fund's website www.athelneytrust.co.uk under "About" then select "Latest Monthly Fact Sheet".

Background Information

Dr. Emmanuel (Manny) Pohl AM

Manny is Chairman and Chief Investment Officer of E C Pohl & Co ("ECP"), an investment management company and has been a major shareholder in Athelney trust for many years.

E C Pohl & co is licensed by the Australian Financial services (license no.421704).

www.ecpohl.com

www.ecpam.com

Manny Pohl and the ECP group has AUD2.7bn (£1.5 billion) under its management including four listed investment companies, three listed in Australia and one in the UK:

· Flagship Investments (ASX code:FSI)

AUD95m https://flagshipinvestments.com.au

· Barrack St Investments (ASX code: BST)

AUD37m www.barrackst.com

· Global Masters Fund Limited (ASX code: GFL)

AUD33m www.globalmastersfund.com.au

· Athelney Trust plc (LSE code: ATY)

GBP6m www.athelneytrust.co.uk

Athelney Trust plc Investment Policy

 The investment objective of the Trust is to provide shareholders with prospects of long-term capital growth with the risks inherent in small cap investment minimised through a spread of holdings in quality small cap companies that operate in various industries and sectors. The Fund Manager also considers that it is important to maintain a progressive dividend record.

The assets of the Trust are allocated predominantly to companies with either a full listing on the London Stock Exchange or a trading facility on AIM or ISDX. The assets of the Trust have been allocated in two main ways: first, to the shares of those companies which have grown steadily over the years in terms of profits and dividends but, despite this progress, the market rating is favourable when compared to future earnings and dividends; second, to those companies whose shares are standing at a favourable level compared with the value of land, buildings or cash in the balance sheet.

Athelney Trust was founded in 1994. In 1996 it was one of the ten pioneer members of the Alternative Investment Market ("AIM"). In 2008 the shares became fully listed on the main market of the London Stock Exchange. Athelney Trust has a successful progressive dividend growth record and the dividend has grown every year since 2004. According to the Association of Investment Companies (AIC) Athelney Trust is one of only "22 investment companies that have increased their dividend every year between 10 and 20 years - the next generation of dividend heroes" (as at 20/03/2018). See link

https://www.theaic.co.uk/income-finder/dividend-heroes

Website

www.athelneytrust.co.uk

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NAVBGBDBGSGDGXS
Date   Source Headline
5th May 20219:19 amRNSNet Asset Value(s)
15th Apr 20219:48 amRNSMajor shareholding notification
15th Apr 20219:46 amRNSMajor shareholder notification
6th Apr 202110:01 amRNSNet Asset Value(s)
30th Mar 20211:20 pmRNSResult of AGM
2nd Mar 202110:11 amRNSNet Asset Value(s)
24th Feb 202112:54 pmRNSAnnual Financial Report
2nd Feb 20219:55 amRNSNet Asset Value(s)
5th Jan 202112:01 pmRNSNet Asset Value(s)
2nd Dec 202012:22 pmRNSNet Asset Value(s)
3rd Nov 20209:30 amRNSNet Asset Value(s)
12th Oct 20209:43 amRNSDirector Declaration
2nd Oct 202011:05 amRNSNet Asset Value(s)
3rd Sep 202010:49 amRNSNet Asset Value(s)
4th Aug 20209:25 amRNSNet Asset Value(s)
4th Aug 20209:21 amRNSMajor Shareholding
28th Jul 20203:36 pmRNSHalf-year Report
15th Jul 20202:14 pmRNSMajor Shareholding
15th Jul 20201:27 pmRNSHolding(s) in Company
15th Jul 20201:24 pmRNSMajor Shareholding
2nd Jul 202012:11 pmRNSNet Asset Value(s)
3rd Jun 20208:35 amRNSNet Asset Value(s)
4th May 20209:32 amRNSNet Asset Value(s)
8th Apr 20204:43 pmRNSAGM Statement
2nd Apr 20209:42 amRNSNet Asset Value(s)
24th Mar 20202:57 pmRNSAGM amendment
11th Mar 20208:23 amRNSDirector/PDMR Shareholding
10th Mar 20202:18 pmRNSHolding(s) in Company
3rd Mar 202010:01 amRNSNet Asset Value(s)
2nd Mar 202011:16 amRNSAnnual Financial Report
5th Feb 20201:21 pmRNSNet Asset Value(s)
3rd Jan 20209:49 amRNSNet Asset Value(s)
4th Dec 201911:05 amRNSNet Asset Value(s)
26th Nov 201910:43 amRNSMajor Shareholder Announcement
26th Nov 201910:43 amRNSHolding(s) in Company
26th Nov 201910:41 amRNSHolding(s) in Company
7th Nov 20191:32 pmRNSHolding(s) in Company
6th Nov 20192:04 pmRNSHolding(s) in Company
5th Nov 20199:13 amRNSNet Asset Value(s)
17th Oct 201912:08 pmRNSAppointment of Alternate Director
3rd Oct 201910:14 amRNSNet Asset Value(s)
5th Sep 201910:04 amRNSNet Asset Value(s)
2nd Aug 20198:21 amRNSNet Asset Value(s)
26th Jul 20191:41 pmRNSHalf-year Report
17th Jul 201910:39 amRNSHolding(s) in Company
17th Jul 201910:20 amRNSDirector notification
12th Jul 20192:20 pmRNSMajor Share Movement
2nd Jul 201912:53 pmRNSNet Asset Value(s)
17th Jun 20191:04 pmRNSDirectors Award
5th Jun 201911:57 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.